Association Between Type 2 Diabetes Mellitus and the Presence of Myocardial Ischemia among Filipino Patients with Stress Myocardial Perfusion Scintigraphy
DOI:
https://doi.org/10.18502/kss.v3i6.2405Abstract
Background: Type 2 DM patients usually had poor prognosis for CAD. MPS with SPECT has been extensively used in CAD detection and it’s application among type 2 DM population is still under study with promising result. In the Philippines, there are no current available data regarding this matter.
Methodology: This was a cross sectional analytical study of randomly selected Filipino patients without previous cardiac events in whom MPS using Thallium-201 were performed over a 24-month period. Association of myocardial ischemia was compared using logistic regression analysis based on total summed stress score (SSS) values.
Results: Total of 208 patients (104 type 2 DM and 104 non-type 2 DM) who underwent stress or pharmacologic MPS using Thallium-201 were included in the study. Majority of the subjects were male. Abnormal 2D echo result and lower EF were significantly present among type 2 DM group (p = 0.044, 0.0005). Hypertension was more prominent among the list of co-morbidities and has significant relationship with type 2 DM group (p = 0.025). The distribution of myocardial ischemia among type 2 DM group with insignificant, mildly abnormal, and moderate to severely abnormal; were 60.6%, 12.5%, and 26.9%, respectively. The presence of having significant CAD (SSS>3) was associated with the type 2 DM group with odds ratio of 2.57 (95% CI: 1.38-4.78, p = 0.003).
Conclusion: The current study has shown that Filipino type 2 DM patients without previous cardiac events are likely to have significant and more severe scintigraphic evidence of CAD than their non-type 2 DM counterpart.
Keywords: coronary artery disease, Filipino type 2 diabetic patients, myocardial perfusion scintigraphy, myocardial ischemia, summed stress score
References
Kasim, M., Currie, G. M., Tjahjono, M., Siswanto, B. B., Harimurti, G. M., & Kiat, H. (2013a). Myocardial Perfusion SPECT Utility in Predicting Cardiovascular Events Among Indonesian Diabetic Patients. The Open Cardiovascular Medicine Journal, 7, 82–89.
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047–1053.
Jimeno C, Abad L, Andag-Silva A, Cunanan E, Fernando RE, Fojas M, editors (2014). PPD: compendium of Philippine medicine. 16
Wackers, F. J. T., Young, L. H., Inzucchi, S. E., Chyun, D. A., Davey, J. A., Barrett, E. J. (2004). Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care, 27(8), 1954–1961.
Yamasaki, Y., Nakajima, K., Kusuoka, H., Izumi, T., Kashiwagi, A., Kawamori, R., Yamada, N., Nishimura, T. (2010). Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care, 33(11), 2320–2326.
Bax, J. J., Inzucchi, S. E., Bonow, R. O., Schuijf, J. D., Freeman, M. R., Barrett, E. J., & Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients with Diabetes. (2007). Cardiac imaging for risk stratification in diabetes. Diabetes Care, 30(5), 1295–1304.
Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M. (2014). The myocardial perfusion scintigraphy in asymptomatic diabetic patients. Iran J Nucl Med, 23:27-35.
DeLuca, A. J., Saulle, L. N., Aronow, W. S., Ravipati, G., & Weiss, M. B. (2005). Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1c with prevalence of silent myocardial ischemia. The American Journal of Cardiology, 95(12), 1472–1474.
Bourque JM, Patel CA, Ali MM, Perez M, Watson D, Beller GA. (2013). Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging. Circulation Cardiovascular Imaging,6(3),466-77.
Mariano-Goulart D. (2007). Myocardial perfusion imaging and cardiac events in asymptomatic patients with diabetes. Heart Metabolism, 35,1-4.
Shmendi, A., Pirie, F., Naidoo, D. P., Tlou, B., Pilloy, W., & Motala, A. A. (2014). Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 545–552.
Leslie, W. D., Tully, S. A., Yogendran, M. S., Ward, L. M., Nour, K. A., & Metge, C. J. (2005). Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 46(2), 204–211.
Senior, R., Monaghan, M., Becher, H., Mayet, J., Nihoyannopoulos, P., & British Society of Echocardiography. (2005). Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography. Heart
(British Cardiac Society), 91(4), 427–436.
Albers, A. R., Krichavsky, M. Z., & Balady, G. J. (2006). Stress testing in patients with diabetes mellitus: diagnostic and prognostic value. Circulation, 113(4), 583–592.
fleischmann, K. E., Hunink, M. G., Kuntz, K. M., & Douglas, P. S. (1998). Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA, 280(10), 913–920.
de Jong, M. C., Genders, T. S. S., van Geuns, R.-J., Moelker, A., & Hunink, M. G. M. (2012). Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. European Radiology, 22(9), 1881–1895.
